Skip to content

Development of a Patient-Reported Outcome–Based Intelligent Platform for Postoperative Symptom Management and Perioperative Rehabilitation in Patients with Gynecologic Malignancies

Development of a Patient-Reported Outcome–Based Intelligent Platform for Postoperative Symptom Management and Perioperative Rehabilitation in Patients with Gynecologic Malignancies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129100
Enrollment
Unknown
Registered
2026-07-31
Start date
2025-03-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Malignancies

Interventions

Gynecological malignant tumor observation group:None

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Female patients aged 18–75 years with histologically confirmed cervical cancer, endometrial cancer, or ovarian cancer who are scheduled to undergo surgical treatment. All participants voluntarily agree to participate in this study and provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients with severe comorbidities, including serious cardiac, pulmonary, or renal diseases, or those with other concomitant malignancies. Patients who decline to participate in this study.

Design outcomes

Primary

MeasureTime frame
The number of symptom threshold events;Chemotherapy delay;

Secondary

MeasureTime frame
Health-related quality of life;Postoperative complications;Enrollment rate;Functional recovery;Chemotherapy-related complications;Chemotherapy completion rate;Progression-free survival;Overall survival ;

Countries

China

Contacts

Public ContactWei Wang

Shanghai First Maternity and Infant Hospital

2405473@tongji.edu.cn+86 21 2026 1234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026